KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Cash (2016 - 2025)

Historic Change in Cash for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $1.0 million.

  • TherapeuticsMD's Change in Cash rose 66540.54% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 14039.85%. This contributed to the annual value of $732000.0 for FY2024, which is 10162.7% up from last year.
  • Latest data reveals that TherapeuticsMD reported Change in Cash of $1.0 million as of Q3 2025, which was up 66540.54% from $324000.0 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Change in Cash ranged from a high of $57.1 million in Q1 2021 and a low of -$39.7 million during Q4 2021
  • Its 5-year average for Change in Cash is -$3.9 million, with a median of -$185000.0 in 2024.
  • Per our database at Business Quant, TherapeuticsMD's Change in Cash plummeted by 476185.45% in 2021 and then surged by 613636.36% in 2025.
  • TherapeuticsMD's Change in Cash (Quarter) stood at -$39.7 million in 2021, then soared by 127.66% to $11.0 million in 2022, then plummeted by 153.14% to -$5.8 million in 2023, then soared by 100.21% to $12000.0 in 2024, then surged by 8616.67% to $1.0 million in 2025.
  • Its Change in Cash was $1.0 million in Q3 2025, compared to $324000.0 in Q2 2025 and $686000.0 in Q1 2025.